摘要
To the Editor:Liver transplantation(LT)is an effective therapeutic method for end-stage liver diseases.Although rejection is commonly mild or moderate in LT compared with other solid organs transplantation,it is still requiring a life-long immunosuppressive therapy.Meanwhile,LT is less sensitive to rejection than other organs transplantation due to liver immune privilege which even allows
基金
supported by grants from National Natural Science Foundation of China(81373160)
Major Program of National Natural Science Foundation of China(91542205)
Zhejiang Provincial Natural Science Foundation of China(LQ15H030003)
